Concordantly, the expression of GFRα1 and GFRα3 was also associated with clinicopathologic features predicting a poor outcome, such as lymph node metastases and tumor stage, whereas the expression of SDC3 was not associated with any such features. The gene discussed is SDC3; the disease is neoplasm.